Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-11-068869)

Filing Details

Accession Number:: 0001144204-11-068869
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-12-07 17:36:56
Reporting Period:: 2011-12-05

Filing Date:: 2011-12-07
Accepted Time:: 2011-12-07 17:36:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1137883	Brainstorm Cell Therapeutics Inc	BCLI]	Biological Products, (No Disgnostic Substances) (2836)	912061050

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197981	L G Robert Shorr	C/O Brainstorm Cell Therapeutics Inc., 605 Third Avenue, 34Th Floor New York NY 10158		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-12-05	98,333	$0.26	230,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The transaction was executed in multiple trades at prices ranging from $0.255 to $0.2565. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.